167 related articles for article (PubMed ID: 23389960)
21. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
[TBL] [Abstract][Full Text] [Related]
22. The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors.
Gyvyte U; Lukosevicius R; Inciuraite R; Streleckiene G; Gudoityte G; Bekampyte J; Valentini S; Salteniene V; Ruzgys P; Satkauskas S; Zviniene K; Kupcinskas J; Skieceviciene J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708220
[TBL] [Abstract][Full Text] [Related]
23. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
24. Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers.
Xu B; Tang G; Xiao C; Wang L; Yang Q; Sun Y
Int J Clin Exp Pathol; 2014; 7(6):2883-93. PubMed ID: 25031707
[TBL] [Abstract][Full Text] [Related]
25. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
[TBL] [Abstract][Full Text] [Related]
27. microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.
Li Y; He S; Zhan Y; He A; Gong Y; Ji G; Huang C; Peng D; Guan B; Li X; Zhou L
DNA Cell Biol; 2019 Aug; 38(8):840-848. PubMed ID: 31314587
[TBL] [Abstract][Full Text] [Related]
28. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
Vera J; Schmitz U; Lai X; Engelmann D; Khan FM; Wolkenhauer O; Pützer BM
Cancer Res; 2013 Jun; 73(12):3511-24. PubMed ID: 23447575
[TBL] [Abstract][Full Text] [Related]
29. Induction of promyelocytic leukemia zinc finger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4.
Dahal S; Chaudhary P; Kim JA
Cell Oncol (Dordr); 2023 Aug; 46(4):1113-1126. PubMed ID: 36995683
[TBL] [Abstract][Full Text] [Related]
30. [Literature-mining and bioinformatic analysis of androgen-independent prostate cancer-specific genes].
Li TQ; Feng CQ; Zou YG; Shi R; Liang S; Mao XM
Zhonghua Nan Ke Xue; 2009 Dec; 15(12):1102-7. PubMed ID: 20180422
[TBL] [Abstract][Full Text] [Related]
31. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
[TBL] [Abstract][Full Text] [Related]
32. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
Yang ZG; Ma XD; He ZH; Guo YX
Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
[TBL] [Abstract][Full Text] [Related]
33. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
[TBL] [Abstract][Full Text] [Related]
34. Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression.
Kim JH; Lee H; Shin EA; Kim DH; Choi JB; Kim SH
Expert Opin Ther Targets; 2017 Sep; 21(9):911-920. PubMed ID: 28816549
[TBL] [Abstract][Full Text] [Related]
35. Gene microarray assessment of multiple genes and signal pathways involved in androgen-dependent prostate cancer becoming androgen independent.
Liu JB; Dai CM; Su XY; Cao L; Qin R; Kong QB
Asian Pac J Cancer Prev; 2014; 15(22):9791-5. PubMed ID: 25520106
[TBL] [Abstract][Full Text] [Related]
36. miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Biochem Biophys Res Commun; 2018 Sep; 503(4):2459-2465. PubMed ID: 29969630
[TBL] [Abstract][Full Text] [Related]
37. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
Zhang X; Pan Y; Fu H; Zhang J
Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer.
Zhao Y; Yan M; Yun Y; Zhang J; Zhang R; Li Y; Wu X; Liu Q; Miao W; Jiang H
Oncol Rep; 2017 Apr; 37(4):2449-2458. PubMed ID: 28350134
[TBL] [Abstract][Full Text] [Related]
39. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study.
Pełka K; Klicka K; Grzywa TM; Gondek A; Marczewska JM; Garbicz F; Szczepaniak K; Paskal W; Włodarski PK
Histochem Cell Biol; 2021 Mar; 155(3):423-433. PubMed ID: 33331954
[TBL] [Abstract][Full Text] [Related]
40. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D
Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
